Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include Viatris, AstraZeneca and Sanofi.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | ||
Founding Date | Founding Date 1901 | Founding Date 2020 | Founding Date 1999 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 37,000 | Employees 38,0003% increase | Employees 94,300 | Employees 82,878 |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 14 b | Valuation ($) 2.7 b | Valuation ($) 141.1 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods $9.3b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit $5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income $1.4b (FY, 2025) | Net income ($3.5b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income €8b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries 130 (FY, 2021) | Countries N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline 91 (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companySanofi
HQ
Paris, FR
Employees
82,878
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company